Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: neuroscience – Page 928

Age Backwards, Biohack Your Life and Be Superhuman | Dave Asprey and Lewis Howes

Thank you for watching this powerful interview with Dave Asprey!
Check out the show notes here: https://www.lewishowes.com/860

Dave Asprey is the creator of the widely-popular Bulletproof Coffee, host of the podcast Bulletproof Radio, and author of the New York Times bestselling book, The Bulletproof Diet.

Dave was described by Men’s Health as a “lifestyle guru” and his body-hacking gym, Upgrade Labs, has more than 15 different technologies dedicated to improving mental and physical performance and recovery. His new book Super Human: The Bulletproof Plan to Age Backward and Maybe Even Live Forever is out on everywhere books are sold online.

So get ready to learn how to biohack your health and energy as you age on Episode 860.

Follow Dave Asprey here:

Home



https://www.instagram.com/dave.asprey
https://www.facebook.com/bulletproofexecutive
https://podcasts.apple.com/us/podcast/bulletproof-radio/id451295014

You can follow Lewis at:

Continue reading “Age Backwards, Biohack Your Life and Be Superhuman | Dave Asprey and Lewis Howes” | >

Study shows extra virgin olive oil staves off multiple forms of dementia in mice

Boosting brain function is key to staving off the effects of aging. And if there was one thing every person should consider doing right now to keep their brain young, it is to add extra virgin olive oil (EVOO) to their diet, according to research by scientists at the Lewis Katz School of Medicine at Temple University (LKSOM). EVOO is a superfood, rich in cell-protecting antioxidants and known for its multiple health benefits, including helping put the brakes on diseases linked to aging, most notably cardiovascular disease. Previous LKSOM research on mice also showed that EVOO preserves memory and protects the brain against Alzheimer’s disease.

In a new study in mice published online in the journal Aging Cell, LKSOM scientists show that yet another group of aging-related diseases can be added to that list—tauopathies, which are characterized by the gradual buildup of an abnormal form of a protein called tau in the . This process leads to a decline in mental function, or dementia. The findings are the first to suggest that EVOO can defend against a specific type of mental decline linked to tauopathy known as frontotemporal dementia.

Alzheimer’s disease is itself one form of dementia. It primarily affects the hippocampus—the memory storage center in the brain. Frontotemporal dementia affects the areas of the brain near the forehead and ears. Symptoms typically emerge between ages 40 and 65 and include changes in personality and behavior, difficulties with language and writing, and eventual deterioration of memory and ability to learn from prior experience.

Studies Show that Breast Milk Grows Premature Infant Brains Faster than Formula

It’s easy to get excited about breast milk. Just the basic fact that a woman can eat food and turn it into a complete food instantly tailored to grow that particular newborn is quite outstanding. But there is more to breast milk than what meets the eye and understanding the perfection of it could mean a better life for premature babies.

For starters, when a baby suckles her mama’s breast, a vacuum is created. That’s right. Saliva in, milk out. The infant’s saliva is sucked back into the mother’s nipple, where receptors in her mammary gland read its signals. Katie Hinde, a biologist and associate professor at the Center for Evolution and Medicine at the School of Human Evolution & Social Change at Arizona State University, calls this “baby spit backwash,” and it contains information about the baby’s immune status. As far as scientists can tell, baby spit backwash is one of the ways that breast milk adjusts its immunological composition. When mammary gland receptors detect the presence of pathogens, the mother’s body produces antibodies to fight it, and those antibodies travel through breast milk back into the baby’s body, where they target the infection.

“[Breast] Milk is so incredibly dynamic,” says Hinde. “There are hormones in breast milk, and they reflect the hormones in the mother’s circulation. The ones that help facilitate sleep or waking up are present in your milk. And day milk is going to have a completely different hormonal milieu than night milk.” That broken-down means that breastmilk made at night contains hormones that help your baby sleep.

FDA Calls Psychedelic Psilocybin a ‘Breakthrough Therapy’ for Severe Depression

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

For the second time in a year, the U.S. Food and Drug Administration (FDA) has designated psilocybin therapy — currently being tested in clinical trials — as “breakthrough therapy,” an action that is meant to accelerate the typically sluggish process of drug development and review. It is typically requested by a drug company and granted only when preliminary evidence suggests the drug may be an enormous improvement over already available therapy, according to the FDA.

The Psychology of Beating an Incurable Illness | Bob Cafaro | TEDxCharlottesville

NOTE FROM TED: Please do not look to this talk for medical advice. This talk, which was filmed at a TEDx event, contains strong assertions about multiple sclerosis and lifestyle medicine that lack sufficient scientific evidence for general prescription. TEDx events are independently organized by volunteers. The guidelines we give TEDx organizers are described in more detail here: http://storage.ted.com/tedx/manuals/tedx_content_guidelines.pdf

After a shocking diagnosis that would begin stripping Bob Cafaro of his ability to perform, sheer willpower and changes to his daily life allow him to beat all odds.

Bob Cafaro played chamber music full time and served on the faculty of the University of Virginia until 1983 when he became a regular with the Metropolitan Opera Orchestra. He later joined the Baltimore Symphony and in 1985 became a member of the Philadelphia Orchestra. In 1999, Bob was stricken with a virulent case of Multiple Sclerosis, which left him nearly blind and without the use of his hands. Defying what doctors had told him, he made a complete and remarkable recovery and has since written a book, been a member of The Rachmaninov Trio since 2003, and has grown passionate in his involvement with volunteer and outreach activities.

This talk was given at a TEDx event using the TED conference format but independently organized by a local community.

Investigators narrow in on a microRNA for treating multiple sclerosis

It turns out the gut is full of surprises. And one of those surprises may have offered up a key for unlocking a new way of treating multiple sclerosis (MS). Investigators from Brigham and Women’s Hospital have discovered a microRNA—a small RNA molecule—that increases during peak disease in a mouse model of MS and in untreated MS patients. When a synthetic version of the microRNA was orally given to the mice, it prevented disease. While several steps remain before these insights can be translated into therapy for patients, the researchers describe their results as both exciting and unexpected. Their findings are published in Cell Host & Microbe.

“We’ve discovered a new mechanism to regulate the microbiome and treat that hadn’t been known before,” said senior author Howard Weiner, MD, co-director of the Ann Romney Center for Neurologic Diseases at the Brigham. “The is known to play an important role in MS and other diseases. Our findings, which show that a microRNA can be used to target and influence the microbiome with precision, may have applicability for MS and many other diseases, including diabetes, ALS, obesity and cancer.”

Weiner, lead author Shirong Liu, MD, Ph.D., an instructor in the Weiner laboratory, and their colleagues investigated how the altered gut microbiome affects the course of MS. To do so, they studied the microbiome and microRNAs found in the experimental autoimmune encephalomyelitis (EAE) model of MS. Unexpectedly, they found that when they transferred fecal matter from EAE mice at peak disease, it protected the mice who received the transfer. The team found that a specific microRNA, known as miR-30d, rather than live bacteria, was responsible for preventing disease. The investigators found that miR-30d is enriched in untreated, relapsing-remitting MS patients as well.

/* */